NDC 51655-017 Carbamazepine
View Dosage, Usage, Ingredients, Routes, UNII
Product Information
- 51655 - Northwind Pharmaceuticals, Llc
- 51655-017 - Carbamazepine
Product Characteristics
Product Packages
NDC Code 51655-017-92
Package Description: 270 TABLET in 1 BOTTLE, DISPENSING
Product Details
What is NDC 51655-017?
What are the uses for Carbamazepine?
Which are Carbamazepine UNII Codes?
The UNII codes for the active ingredients in this product are:
- CARBAMAZEPINE (UNII: 33CM23913M)
- CARBAMAZEPINE (UNII: 33CM23913M) (Active Moiety)
What is the NDC to RxNorm Crosswalk for Carbamazepine?
- RxCUI: 308979 - carBAMazepine 200 MG Oral Tablet
- RxCUI: 308979 - carbamazepine 200 MG Oral Tablet
* Please review the disclaimer below.
Patient Education
Carbamazepine
Carbamazepine is used alone or in combination with other medications to control certain types of seizures in people with epilepsy. It is also used to treat trigeminal neuralgia (a condition that causes facial nerve pain). Carbamazepine extended-release capsules (Equetro brand only) are also used to treat episodes of mania (frenzied, abnormally excited or irritated mood) or mixed episodes (symptoms of mania and depression that happen at the same time) in patients with bipolar I disorder (manic-depressive disorder; a disease that causes episodes of depression, episodes of mania, and other abnormal moods). Carbamazepine is in a class of medications called anticonvulsants. It works by reducing abnormal electrical activity in the brain.
[Learn More]
* Please review the disclaimer below.
[5] What is the Labeler Name? - Name of Company corresponding to the labeler code segment of the Product NDC.
[9] What is the Start Marketing Date? - This is the date that the labeler indicates was the start of its marketing of the drug product.
[11] What is the Listing Expiration Date? - This is the date when the listing record will expire if not updated or certified by the product labeler.
[12] What is the NDC Exclude Flag? - This field indicates whether the product has been removed/excluded from the NDC Directory for failure to respond to FDA"s requests for correction to deficient or non-compliant submissions ("Y"), or because the listing certification is expired ("E"), or because the listing data was inactivated by FDA ("I"). Values = "Y", "N", "E", or "I".